FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

409405006: Product containing bevacizumab (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2464856011 Bevacizumab (product) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
2471191018 Bevacizumab en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3522874013 Product containing bevacizumab (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3522875014 Product containing bevacizumab en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3667106018 Bevacizumab product en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3713532017 Bevacizumab-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3600481000005112 bevacizumab da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing bevacizumab (medicinal product) Is a Product containing angiogenesis inhibitor (product) true Inferred relationship Some
Product containing bevacizumab (medicinal product) Is a Product containing monoclonal antibody (product) true Inferred relationship Some
Product containing bevacizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Monoclonal antibody false Inferred relationship Some
Product containing bevacizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bevacizumab (substance) true Inferred relationship Some 1
Product containing bevacizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Immunosuppressant (substance) false Inferred relationship Some
Product containing bevacizumab (medicinal product) Is a antineoplastisk middel false Inferred relationship Some
Product containing bevacizumab (medicinal product) Plays role Antineoplastic therapeutic role false Inferred relationship Some
Product containing bevacizumab (medicinal product) Is a Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 4 ml Is a False Product containing bevacizumab (medicinal product) Inferred relationship Some
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml Is a False Product containing bevacizumab (medicinal product) Inferred relationship Some
Product containing bevacizumab in parenteral dose form (medicinal product form) Is a True Product containing bevacizumab (medicinal product) Inferred relationship Some
Bevacizumab only product Is a True Product containing bevacizumab (medicinal product) Inferred relationship Some

Reference Sets

GB English

Back to Start